Cargando…
Potential of angiotensin II receptor blocker telmisartan in reducing mortality among hospitalized patients with COVID-19 compared with recommended drugs
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Nature Singapore
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9462647/ https://www.ncbi.nlm.nih.gov/pubmed/36085147 http://dx.doi.org/10.1038/s41421-022-00454-7 |
| _version_ | 1784787233349304320 |
|---|---|
| author | Liu, Dengyuan Wu, Peng Gu, Wentao Yang, Cuihong Yang, Xinmeng Deng, Xingyu Xu, Jun Jiang, Jingmei Jiang, Chengyu |
| author_facet | Liu, Dengyuan Wu, Peng Gu, Wentao Yang, Cuihong Yang, Xinmeng Deng, Xingyu Xu, Jun Jiang, Jingmei Jiang, Chengyu |
| author_sort | Liu, Dengyuan |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9462647 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Springer Nature Singapore |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94626472022-09-10 Potential of angiotensin II receptor blocker telmisartan in reducing mortality among hospitalized patients with COVID-19 compared with recommended drugs Liu, Dengyuan Wu, Peng Gu, Wentao Yang, Cuihong Yang, Xinmeng Deng, Xingyu Xu, Jun Jiang, Jingmei Jiang, Chengyu Cell Discov Correspondence Springer Nature Singapore 2022-09-09 /pmc/articles/PMC9462647/ /pubmed/36085147 http://dx.doi.org/10.1038/s41421-022-00454-7 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Correspondence Liu, Dengyuan Wu, Peng Gu, Wentao Yang, Cuihong Yang, Xinmeng Deng, Xingyu Xu, Jun Jiang, Jingmei Jiang, Chengyu Potential of angiotensin II receptor blocker telmisartan in reducing mortality among hospitalized patients with COVID-19 compared with recommended drugs |
| title | Potential of angiotensin II receptor blocker telmisartan in reducing mortality among hospitalized patients with COVID-19 compared with recommended drugs |
| title_full | Potential of angiotensin II receptor blocker telmisartan in reducing mortality among hospitalized patients with COVID-19 compared with recommended drugs |
| title_fullStr | Potential of angiotensin II receptor blocker telmisartan in reducing mortality among hospitalized patients with COVID-19 compared with recommended drugs |
| title_full_unstemmed | Potential of angiotensin II receptor blocker telmisartan in reducing mortality among hospitalized patients with COVID-19 compared with recommended drugs |
| title_short | Potential of angiotensin II receptor blocker telmisartan in reducing mortality among hospitalized patients with COVID-19 compared with recommended drugs |
| title_sort | potential of angiotensin ii receptor blocker telmisartan in reducing mortality among hospitalized patients with covid-19 compared with recommended drugs |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9462647/ https://www.ncbi.nlm.nih.gov/pubmed/36085147 http://dx.doi.org/10.1038/s41421-022-00454-7 |
| work_keys_str_mv | AT liudengyuan potentialofangiotensiniireceptorblockertelmisartaninreducingmortalityamonghospitalizedpatientswithcovid19comparedwithrecommendeddrugs AT wupeng potentialofangiotensiniireceptorblockertelmisartaninreducingmortalityamonghospitalizedpatientswithcovid19comparedwithrecommendeddrugs AT guwentao potentialofangiotensiniireceptorblockertelmisartaninreducingmortalityamonghospitalizedpatientswithcovid19comparedwithrecommendeddrugs AT yangcuihong potentialofangiotensiniireceptorblockertelmisartaninreducingmortalityamonghospitalizedpatientswithcovid19comparedwithrecommendeddrugs AT yangxinmeng potentialofangiotensiniireceptorblockertelmisartaninreducingmortalityamonghospitalizedpatientswithcovid19comparedwithrecommendeddrugs AT dengxingyu potentialofangiotensiniireceptorblockertelmisartaninreducingmortalityamonghospitalizedpatientswithcovid19comparedwithrecommendeddrugs AT xujun potentialofangiotensiniireceptorblockertelmisartaninreducingmortalityamonghospitalizedpatientswithcovid19comparedwithrecommendeddrugs AT jiangjingmei potentialofangiotensiniireceptorblockertelmisartaninreducingmortalityamonghospitalizedpatientswithcovid19comparedwithrecommendeddrugs AT jiangchengyu potentialofangiotensiniireceptorblockertelmisartaninreducingmortalityamonghospitalizedpatientswithcovid19comparedwithrecommendeddrugs |